Location History:
- Kanagawa, JP (1993 - 2006)
- Tokyo, JP (2018)
Company Filing History:
Years Active: 1993-2018
Title: Emi Tamechika: Innovator in Blood Coagulation Testing
Introduction
Emi Tamechika is a notable inventor based in Tokyo, Japan. She has made significant contributions to the field of medical technology, particularly in blood coagulation testing. With a total of 4 patents to her name, Tamechika's work is paving the way for advancements in diagnostic methods.
Latest Patents
One of Tamechika's latest patents is a blood coagulation test method. This innovative method involves introducing a specimen containing blood plasma and a coagulation activating agent into a flow channel. The coagulation activating agent is strategically positioned ahead, allowing for a series of interactions between the components. The refractive indices of the coagulation activating agent and the contact region are measured in a time-series manner to assess the blood coagulation ability of the specimen.
Another significant invention is a flow cell and liquid feed system. This system includes a plate-shaped body with an introduction portion and a channel formed inside. The design allows for better control of the feed of trace amounts of liquid, enhancing the efficiency of liquid handling in various applications.
Career Highlights
Emi Tamechika is currently employed at Nippon Telegraph and Telephone Corporation, where she continues to innovate and develop new technologies. Her work has garnered attention for its practical applications in the medical field, particularly in improving diagnostic accuracy.
Collaborations
Tamechika has collaborated with several talented individuals, including her coworkers Suzuyo Inoue and Katsuyoshi Hayashi. These collaborations have contributed to the successful development of her patented technologies.
Conclusion
Emi Tamechika is a pioneering inventor whose work in blood coagulation testing and liquid feed systems is making a significant impact in medical diagnostics. Her contributions are essential for advancing technology in this critical field.